Tenax Therapeutics (TENX) Earnings Analysis

Tenax Therapeutics (TENX) next reports earnings on 2026-08-12, consensus EPS -0.38 USD. Last quarter (2026-03-10) it beat with EPS -0.38 USD vs -1.26 USD est (+69.8%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -10.49.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does TENX next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.38 USD
Revenue estimaten/a

TENX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-10-0.38 USD-1.26 USD+69.8%Beat
2025-11-12-0.4 USD-1.33 USD+69.9%Beat
2025-08-13-0.27 USD-0.5 USD+46%Beat
2025-05-14-0.28 USD-0.48 USD+41.7%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

TENX valuation and analyst view

Trailing P/E-10.49
Trailing EPS-1.28038 USD
Price / book5.83
Dividend yield0.00%
Market cap0.25B
Analyst consensusBuy (6 buy / 0 hold / 0 sell)
Avg price target33.5 USD

Related research pages

Frequently asked questions

When is Tenax Therapeutics (TENX)'s next earnings date?

Tenax Therapeutics is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.38 USD.

Did TENX beat earnings last quarter?

In its 2026-03-10 report, TENX posted EPS of -0.38 USD versus a -1.26 USD estimate — a beat of 69.8%.

What is TENX's earnings track record?

Over the last 4 reported quarters with consensus data, TENX beat estimates 4 times (100%).

What is TENX's current P/E ratio and EPS?

TENX trades at a trailing P/E of -10.49 on trailing EPS of -1.2803825240908349 USD.

What do analysts rate TENX?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 33.5 USD.